WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has issued an announcement.
WuXi AppTec Co., Ltd. has announced the convening of its 2025 First H Share Class Meeting, scheduled for April 29, 2025, in Shanghai, China. The primary agenda is to consider a special resolution granting the Board of Directors a mandate to repurchase up to 10% of the company’s A and H shares, subject to regulatory approvals and certain conditions. This move could potentially impact the company’s share value and market positioning, reflecting a strategic decision to manage its capital structure and shareholder value.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the pharmaceutical and biotechnology industry. It provides comprehensive and integrated services, including drug discovery, development, and manufacturing, catering to the global pharmaceutical and healthcare sectors.
YTD Price Performance: 22.74%
Average Trading Volume: 6,118,226
Technical Sentiment Signal: Sell
Current Market Cap: HK$204B
For detailed information about 2359 stock, go to TipRanks’ Stock Analysis page.